Elite Pharmaceuticals, Inc. Current Liabilities
Elite Pharmaceuticals, Inc. (ELTP) had Current Liabilities of $30.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $30.44M.
- 2026-03-31: Liabilities, Current $17.39M.
- 2025-12-31: Liabilities, Current $13.19M.
- 2025-09-30: Liabilities, Current $10.67M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $30.44M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $17.39M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $13.19M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $10.67M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $10.76M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.84M 10-K · filed 2026-06-29 | |
| 2024-12-31 | $14.69M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $12.85M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $14.01M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $13.05M 10-K · filed 2025-06-30 | |
| 2023-12-31 | $19.16M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $19.08M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $12.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.83M 10-K · filed 2024-07-01 | |
| 2022-12-31 | $6.65M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $6.84M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.08M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.69M 10-K · filed 2023-06-29 | |
| 2021-12-31 | $5.88M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $6.30M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $6.80M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $5.81M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $7.24M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $7.01M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $8.64M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $8.64M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $7.75M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $7.17M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.61M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.91M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $6.94M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $5.36M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $4.67M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $5.11M 10-K · filed 2019-06-21 | |
| 2017-12-31 | $4.74M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $3.65M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.51M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.34M 10-K · filed 2018-06-14 | |
| 2016-12-31 | $4.68M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $5.14M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.38M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $4.64M 10-K · filed 2017-06-14 | $4.65M 10-K · filed 2016-06-15 |
| 2015-12-31 | $5.36M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $5.51M 10-Q · filed 2015-12-30 | $4.51M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $4.36M 10-Q · filed 2015-12-30 | $3.36M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $5.07M 10-K · filed 2016-06-15 | |
| 2014-12-31 | $4.35M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $3.81M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $7.31M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $6.16M 10-K · filed 2015-06-15 | |
| 2013-12-31 | $12.51M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $11.72M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $5.31M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $5.36M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $5.38M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $4.76M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.76M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $4.55M 10-K · filed 2013-06-21 | |
| 2011-12-31 | $4.72M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $4.47M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.63M 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | $4.67M 10-K · filed 2012-06-29 |